Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. - Wikidata - awgldk - TriplyDB

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

http://www.wikidata.org/entity/Q40842954

about

Evidence that SOX2 overexpression is oncogenic in the lung The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis.Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.The p53 target Wig-1: a regulator of mRNA stability and stem cell fate?The SOX family of genes in cancer development: biological relevance and opportunities for therapy.Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.Roles of eukaryotic initiation factor 5A2 in human cancer.The dark side of SOX2: cancer - a comprehensive overview.Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Ecotropic viral integration site 1, a novel oncogene in prostate cancer.Zinc induces cell cycle arrest and apoptosis by upregulation of WIG-1 in esophageal squamous cancer cell line EC109.Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma.Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma.Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients.Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.Human wig-1, a p53 target gene that encodes a growth inhibitory zinc finger protein.Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis.DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma

P2860

Q21091126-D5CE7E28-EA88-4A46-9045-38AE6CA2E595 Q24309520-1AC59E6E-069C-4001-B072-666693B2503E Q24317766-4E9F8C16-3A05-444A-AAA2-9BC69B782EC6 Q28082535-C7577150-8D79-4BFF-8153-8A08C60D5A46 Q28213364-C7DBD108-7329-423E-8EF5-D0192DC0F393 Q28289164-CB98CE45-6F4E-437C-9842-210521454FBB Q33645670-37A132ED-2D32-4A30-A294-F0F4B784EFC7 Q33806378-4C3B2419-37A1-4ACC-8916-FEDEAF952575 Q33863504-51C3FC03-9873-4764-9F5B-A258DBD49472 Q33869598-C105BEB0-CE00-4A28-A3B7-D16ECD5AC3DF Q33875325-86A91803-1A88-4FC8-A0DC-6F23CF803FD6 Q33901136-BBC09730-4385-4A49-87CB-E47064660855 Q35872473-E40F6842-9D9E-41B5-B485-054DCFF9E90D Q36686743-1A810801-E012-4348-A24A-E14F89516BF3 Q37582166-C86172E0-EF7B-40E4-9FC2-5C6458A52B15 Q37801949-C929A2E9-F1BD-4710-89D6-8C96F2D81922 Q37851826-61DE183A-C360-473D-9203-56B9A2B2A58E Q38029732-6A367553-527A-4277-A774-C116E4B0E268 Q38053346-63FE1A52-728B-45BF-B8AE-DADD771E48F4 Q38163977-DABDDED1-E774-429B-B211-47AF33301704 Q38733504-3557BF58-342B-42D4-B543-5BC336678771 Q39143949-EAC19459-6E3C-4D90-9390-F239D32C0EA9 Q39186868-66B813D9-F2A4-4970-B934-7E99DB89A5BC Q39401617-20AD2AA6-E5BC-4BDF-AAEC-120C389DA14E Q39544853-9E4B8A2E-91E2-4B2C-8820-D15706472D27 Q39673958-2A5EE0EA-F5E8-4F90-A549-ADA5383BE11F Q39932407-13572FF3-6BFC-4B5E-9F1D-CE5EC0B5C2C8 Q40890713-D80C2E8D-5635-432D-98A3-6CF88F96F5A8 Q42322572-E94AD98B-3F22-49C7-B2A7-206DD63B5FA7 Q42399058-80C66D54-E567-437F-9DC6-6C420A05F454 Q42509097-8C4AAC98-0D2B-4D76-859A-837D79CB8AF8 Q42639936-81F26A91-7794-41EB-AB8E-19B170256BBD Q48341534-37D02BFD-F791-4771-A475-66266337C6E2 Q53684290-2C85E791-F056-47AB-BC5F-8C6770462156 Q58408122-CB27457F-AAF8-4B35-B297-8DAA2FED37FA

P2860

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

http://www.wikidata.org/entity/Q40842954

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

@en

type

label

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

@en

prefLabel

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

@en

P1433

Q40842954-78E72D46-297D-4C07-AD87-8BE00B6759ED

P1476

Q40842954-3A848459-F896-4CB4-994A-1FBBF3C141EB

P2093

Q40842954-1ECD5A49-F62A-4D50-82C7-EA9277E5D1FA

Q40842954-1EEB43B9-334A-4CA5-8699-7993FA5CF623

Q40842954-29DAE1B8-1427-444C-B09B-FDE3B89C62A3

Q40842954-3058BECB-71CB-4BE3-9F64-7F12C0727304

Q40842954-33AADC8B-EA22-41F6-A79F-141BA7271CD8

Q40842954-5F135341-C02B-4EDF-9E0B-A714BA174C7F

Q40842954-76DF70C2-5A49-4E69-84F4-0A220D07DE81

Q40842954-AE91FE31-8606-4DE8-B7A1-A0E0A879CB97

Q40842954-B20ADE0F-E4EC-4027-BF1D-33E577F9EC28

Q40842954-E365841F-FA7C-4B18-9EEE-4DFE3B996B1A

P2860

Q40842954-19CF3BF4-3611-404A-BBEF-C475AE053875

Q40842954-3AF06BAA-B44E-495D-A0E4-88480467F5A6

Q40842954-3D337E07-6530-4EBA-B2D8-7DD8CEA3DA97

Q40842954-66F89DDD-EAB8-4A63-907D-7F5892EBE769

Q40842954-69480E87-0907-42EB-AAEF-1BDFCFE584D0

Q40842954-6DF3B3F3-DC47-419A-BAD0-3046F8EB1AEA

Q40842954-70F6A4B5-91C2-4481-B933-2C1C86809666

Q40842954-768F8C7D-28C8-407F-B592-CA5DE7638679

Q40842954-A2087894-FF4D-4112-AD20-9F0C029C8181

Q40842954-AB095253-1526-423E-AF47-E2451E0870A4

P304

Q40842954-7550BE97-4B02-4424-8C17-1E8E6F9F64BB

P31

Q40842954-4D9E61A5-BF48-489B-89CD-9684CBDBBBF9

P356

Q40842954-B042F411-0052-4706-A081-3E803BB664EF

P433

Q40842954-85537A1A-CCD9-4907-9D2B-963217AC0807

P478

Q40842954-1F79C00B-97C2-4F77-8052-EFC12FA5FCDC

P577

Q40842954-A3ACA285-510C-44FB-857E-E6E97964B8ED

P698

Q40842954-F8E66711-0633-4F20-8189-3C3D47B6F35F

P356

1097-0045(20001101)45:3%3C207::AID-PROS2%3E3.0.CO;2-H

P1433

P1476

Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.

@en

P2093

Bex A

http://www.w3.org/2001/XMLSchema#string

Bonkhoff H

http://www.w3.org/2001/XMLSchema#string

Lensch R

http://www.w3.org/2001/XMLSchema#string

Meese E

http://www.w3.org/2001/XMLSchema#string

Retz M

http://www.w3.org/2001/XMLSchema#string

Rohde V

http://www.w3.org/2001/XMLSchema#string

Sattler HP

http://www.w3.org/2001/XMLSchema#string

Stoeckle M

http://www.w3.org/2001/XMLSchema#string

Wullich B

http://www.w3.org/2001/XMLSchema#string

Zimmer E

http://www.w3.org/2001/XMLSchema#string

P2860

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.

Isolation of a human prostate carcinoma cell line (DU 145).

In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

The ovine SOX2 gene: sequence, chromosomal localization and gonadal expression.

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.

Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung.

P304

207-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11074522

http://www.w3.org/2001/XMLSchema#string